OmniComm Systems Inc., Introduces New TrialMaster V.4.0 At the Dia's 42nd Annual Meeting in Philadelphia

June 18-20th 2006 / Booth #1144

Ft. Lauderdale, Florida – June 18th, 2006 - - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, announced today the launch of TrialMaster™ Version 4.0 eClinical trial solution. 

Rusty Beardsley, Executive Vice President, Commercial Development, commenting on the New TrialMaster™ Version 4.0 said, “At OmniComm, we have focused on simplifying trial building, streamlining data entry processes, and integrating our technology to optimize the eClinical trial process”. 

Beardsley continues: “TrialMaster™ Version. 4.0 delivers what the market has been waiting for long enough, at an affordable price and without the typical inconveniences that have troubled sponsors for some time.   When implementing TrialMaster™ Version 4.0, clients will have More Speed, More Flexibility, More Control of their data in the business model of their choice (ASP, Technology Transition or Technology Transfer).” 
TrialMaster™ Version 4.0 includes:

• eData Capture functionality
• Data Management functionality
• Trial Management functionality
• Easy Trial Build capability.

Phase I through Phase IV, Beardsley says, “If you have not been satisfied with your past EDC experience or are ready for change, come by the booth and let us introduce you to New TrialMaster™ Version.4.0. - The flexible, painless and affordable eClinical Solution – we’re confident you will be impressed!”

About OmniComm Systems, Inc.

OmniComm Systems, Inc. is one of the fastest growing companies in the EDC market place targeting its product TrialMaster® to the pharmaceutical, medical device and biotechnology companies as well as CRO’s.  OmniComm’s growing base of satisfied customers is a direct result of OmniComm’s employee’s commitment to on-time, quality and within budget performance. 
The TrialMaster system, the core product of OmniComm, provides trial sponsors with a 21 CRF Part 11 compliant Internet-based data and trial management solution that greatly increases the efficiency, security and integrity of clinical research data and thus significantly reduces the time and expense involved in conducting clinical studies.

Safe Harbor Disclaimer

Statements about OmniComm’s future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm’s operations, markets and profitability, actual results could differ materially and adversely from the expected results.

(Picture available upon request, Please email: info@omnicomm.com)

For more information or a demonstration, please email info@omnicomm.com

Back